This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
29. In Schedule 3 to the principal Regulations (particulars and documents that must accompany an application for an ethics committee opinion, a request for authorisation, a notice of amendment and a notification of the conclusion of a trial)—
(a)in Part 2 (request for authorisation), in paragraph 1, in sub-paragraph (b), for “the European Community” substitute “an EEA State”;
(b)in Part 3 (notice of amendment)—
(i)in paragraph 1, in sub-paragraph (b), for “the European Community” substitute “an EEA State”, and
(ii)in paragraph 2, in sub-paragraph (b), for “the number” substitute “any number”; and
(c)in Part 4 (notification of conclusion of a clinical trial)—
(i)in paragraph 1, in sub-paragraph (b), for “the European Community” substitute “an EEA State”, and
(ii)in paragraph 2, in sub-paragraph (b), for “the number” substitute “any number”.
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
